Title	Overall response rate
Number of patients screened	16
Number of patients enrolled	16
Number of patients evaluable for toxicity	15
Number of patients evaluated for efficacy	15
Evaluation method	RECIST 1.1
Response assessment CR	n = 1 (6.7%)
Response assessment PR	n = 0 (0%)
Response assessment SD	n = 7 (46.7%)
Response assessment PD	n = 7 (46.7%)
Response assessment OTHER	n = 0 (0%)
(Median) duration assessments PFS	2.4 months, CI: 0.0-5.2
(Median) duration assessments OS	9.7 months, CI: 8.2-11.2
(Median) duration assessments duration of treatment	1.9 months